Metabolic reprogramming of osteoclasts represents a therapeutic target during the treatment of osteoporosis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
In: https://pubmed.ncbi.nlm.nih.gov/33273570/ . - 10.1038/s41598-020-77892-4
Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Dissertation, 2022
- Keyword
-
Osteoporosis
Osteoclasts
- Event
-
Veröffentlichung
- (where)
-
Erlangen
- (who)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (when)
-
2022
- Creator
- Contributor
-
Scholtysek, Carina
Krönke, Gerhard
- URN
-
urn:nbn:de:bvb:29-opus4-199099
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:25 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Taubmann, Jule
- Scholtysek, Carina
- Krönke, Gerhard
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Time of origin
- 2022
Other Objects (12)
Metabolic reprogramming of osteoclasts represents a therapeutic target during the treatment of osteoporosis
Characterisation of genetic regulatory effects for osteoporosis risk variants in human osteoclasts
Smart osteoclasts targeted nanomedicine based on amorphous CaCO3 for effective osteoporosis reversal
Osteoporosis : pathophysiology and therapeutic options
LncRNA TUG1 was upregulated in osteoporosis and regulates the proliferation and apoptosis of osteoclasts
P2X7Rs: new therapeutic targets for osteoporosis
ATR represents a therapeutic vulnerability in clear cell renal cell carcinoma
ROR1 is upregulated in endometrial cancer and represents a novel therapeutic target
Retraction Note: LncRNA TUG1 was upregulated in osteoporosis and regulates the proliferation and apoptosis of osteoclasts
MANTOWN REPRESENTS "iBO"
The splicing machinery is dysregulated and represents a therapeutic vulnerability in breast cancer
JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors
Metabolic reprogramming of osteoclasts represents a therapeutic target during the treatment of osteoporosis
Characterisation of genetic regulatory effects for osteoporosis risk variants in human osteoclasts
Smart osteoclasts targeted nanomedicine based on amorphous CaCO3 for effective osteoporosis reversal
Osteoporosis : pathophysiology and therapeutic options
LncRNA TUG1 was upregulated in osteoporosis and regulates the proliferation and apoptosis of osteoclasts
P2X7Rs: new therapeutic targets for osteoporosis
ATR represents a therapeutic vulnerability in clear cell renal cell carcinoma
ROR1 is upregulated in endometrial cancer and represents a novel therapeutic target
Retraction Note: LncRNA TUG1 was upregulated in osteoporosis and regulates the proliferation and apoptosis of osteoclasts
MANTOWN REPRESENTS "iBO"
The splicing machinery is dysregulated and represents a therapeutic vulnerability in breast cancer
JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors
Metabolic reprogramming of osteoclasts represents a therapeutic target during the treatment of osteoporosis
Characterisation of genetic regulatory effects for osteoporosis risk variants in human osteoclasts
Smart osteoclasts targeted nanomedicine based on amorphous CaCO3 for effective osteoporosis reversal
Osteoporosis : pathophysiology and therapeutic options
LncRNA TUG1 was upregulated in osteoporosis and regulates the proliferation and apoptosis of osteoclasts
P2X7Rs: new therapeutic targets for osteoporosis
ATR represents a therapeutic vulnerability in clear cell renal cell carcinoma
ROR1 is upregulated in endometrial cancer and represents a novel therapeutic target
Retraction Note: LncRNA TUG1 was upregulated in osteoporosis and regulates the proliferation and apoptosis of osteoclasts
MANTOWN REPRESENTS "iBO"
The splicing machinery is dysregulated and represents a therapeutic vulnerability in breast cancer